- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Acute coronary syndrome
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 635KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 154KB)
Prasugrel – March 2024
Prasugrel: Tablet 5 mg, Tablet 10 mg; Prasugrel SCP™
Last updated
30 May 2025